Galderma (makers of Restylane, Sculptra, and Dysport), Allergan (makers of Juvederm, Kybella, and Botox), and Merz (makers of Xeomin and Radiesse) all award physicians based on skill and experience
In the future, Jiabei Health Technology Co., Ltd
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
Handling Guidelines Proper handling practices help maintain peptide stability and reduce contamination risks in laboratory environments